These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19999478)

  • 21. Utilization of ovarian cancer screening by women at increased risk.
    Schwartz M; Lerman C; Daly M; Audrain J; Masny A; Griffith K
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):269-73. PubMed ID: 7606202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
    Meeuwissen PA; Seynaeve C; Brekelmans CT; Meijers-Heijboer HJ; Klijn JG; Burger CW
    Gynecol Oncol; 2005 May; 97(2):476-82. PubMed ID: 15863147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical assessment, gross examination, frozen section of ovarian masses: do patients benefit?
    Ghaemmaghami F; Fakour F; Karimi Zarchi M; Behtash N; Modares Gilani M; Mousavi A; Shariat M
    Arch Gynecol Obstet; 2008 Sep; 278(3):209-13. PubMed ID: 18259768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening the postmenopausal ovary.
    Nachtigall LE
    Menopause; 2009; 16(6):1092. PubMed ID: 19779315
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
    Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME
    J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial ovarian cancer screening.
    Stirling D; Porteous ME; Evans DG; Pichert G; Steel M
    J Clin Oncol; 2006 Feb; 24(6):e11. PubMed ID: 16484689
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients.
    Fehm T; Heller F; Krämer S; Jäger W; Gebauer G
    Anticancer Res; 2005; 25(3A):1551-4. PubMed ID: 16033059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Familial ovarian carcinoma].
    Speiser P
    Wien Med Wochenschr; 1996; 146(1-2):10-3. PubMed ID: 8835489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study.
    Bosse K; Rhiem K; Wappenschmidt B; Hellmich M; Madeja M; Ortmann M; Mallmann P; Schmutzler R
    Gynecol Oncol; 2006 Dec; 103(3):1077-82. PubMed ID: 16904167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of Ca 125 in pelvic masses. Our experience].
    Rotondi M; Lauro C; Ammaturo FP; Guerriero V; Rasile M; Panariello S
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):51-4. PubMed ID: 11526720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NIH Consensus 1994: screening.
    Kramer BS; Gohagan J; Prorok PC
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S20-1. PubMed ID: 7835804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High percentage of abnormal findings on TVU needs further discussion.
    Mourits MJ; van der Velde NM; Arts HJ; de Bock GH
    Br J Cancer; 2006 Oct; 95(8):1125; author reply 1126-7. PubMed ID: 17047659
    [No Abstract]   [Full Text] [Related]  

  • 33. Population screening and early detection of ovarian cancer in asymptomatic women.
    Nelson AE; Francis JE; Zorbas H;
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):448-50. PubMed ID: 19780723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 35. Can you screen for ovarian cancer?
    Hicks ML; Parham G
    J Natl Med Assoc; 1995 Feb; 87(2):109-12. PubMed ID: 7897681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial ovarian screening--effective or ineffective?
    Jacobs IJ; Mackay J; Menon U; Skates SJ; Rosenthal AN; Fraser L
    Br J Cancer; 2006 Oct; 95(8):1124; author reply 1126-7. PubMed ID: 17047658
    [No Abstract]   [Full Text] [Related]  

  • 37. Genomic tests for ovarian cancer detection and management.
    Myers ER; Havrilesky LJ; Kulasingam SL; Sanders GD; Cline KE; Gray RN; Berchuck A; McCrory DC
    Evid Rep Technol Assess (Full Rep); 2006 Oct; (145):1-100. PubMed ID: 17764207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative assessment of ovarian tumors by CA 125 measurement and transvaginal color Doppler ultrasound.
    Kupesić S; Vujisić S; Kurjak A; Mihaljević D; Radosević S
    Acta Med Croatica; 2002; 56(1):3-10. PubMed ID: 12455447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mass-screening for ovarian cancer].
    Sato S; Higuchi T; Yokoyama Y; Sakamoto T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():601-4. PubMed ID: 15535316
    [No Abstract]   [Full Text] [Related]  

  • 40. Ovarian cancer screening.
    Rosenthal A; Jacobs I
    Semin Oncol; 1998 Jun; 25(3):315-25. PubMed ID: 9633843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.